lundi 9 mai 2016

Onco Actu du 9 mai 2016

1. Biologie

Shining a light on bladder cancer [Broad Institute of MIT and Harvard]

2.4 Etiologie - Portables, ondes e-m

New study: no increase in brain cancer across 29 years of mobile use in Australia [The Conversation]

3.1 Tabac

India's ITC resumes cigarette production with larger health warnings [Reuters]

UK’s policy on standardised tobacco packaging given EU backing [Cancer Research UK]

California raises age to purchase tobacco to 21 [Reuters]

India's ITC shuts cigarette plants from May 4 [Reuters]

Extending Authorities to All Tobacco Products, Including E-Cigarettes, Cigars, and Hookah [FDA]

3.1.1 Tabac - e-cigs

We Need To Fill The Gap Between What We Know And Don’t Know About E-cigarettes [Health Affairs]

The Wild West of e-cigarettes just ended with a new, sweeping federal rule [Vox]

Doctors see big loophole in FDA action against e-cigarettes and want it closed [LA Times]

E-cigarettes' effect on public health an open question, which the FDA will try to answer [LA Times]

FDA issues sweeping regulations for e-cigarettes for first time [STAT]

4. Dépistage, diagnostic et pronostic

Using molecular imaging to take a snapshot of cancer and its treatment [The Institute of Cancer Research]

4.12 Biopsies liquides

Foundation Medicine Announces Commercial Launch of Liquid Biopsy Assay, FoundationACT™ [Foundation Medicine]

5. Traitements

Laser brain cancer treatment may bring extra advantage [Reuters]

Nanoparticles Mix It Up With Reality [In the Pipeline]

5.12 Immunothérapies

Second baby gets Cellectis designer cells to clear leukaemia [Reuters]

14th CIMT Annual Meeting [CIMT]

5.12.2 Immunothérapies - CAR-T

Rockstar researcher licenses out new CAR-T platform to upstart [FierceBiotech]

5.2 Pharma

FDA grants Eli Lilly a priority review for soft tissue sarcoma drug [FierceBiotech]

Phase III Trial of Regorafenib in Patients with Unresectable Liver Cancer Meets Primary Endpoint of Improving Overall Survival [Bayer]

5.2.2 Pharma - Fusions & Acquisitions

Amgen Said to Join Health-Care Pack Weighing Medivation Bids [Bloomberg]

Medivation Reiterates Rejection of Sanofi's Substantially Inadequate Proposal [Medivation]

Sanofi Sends Letter to Medivation’s Board of Directors [Sanofi]

5.2.3 Pharma - économie

Clovis hatchets 35% of staff and buries its lung cancer drug roci [FierceBiotech]

Clovis Oncology Announces Q1 2016 Operating Results and Corporate Update [Clovis Oncology]

5.3 Traitements - FDA, EMA,...

Regulating Precision Medicine: Capacity vs. Overreach [RAPS]

5.4 Traitements - Economie

Focus: Governments evaluate policies, reforms as drug pricing debate rages on [Pharmafile]

Independent group finds multiple myeloma drugs too costly in U.S [Reuters]

Merck fights with New Zealand over coverage of its Keytruda cancer drug [STAT]

5.9 AACR

More pieces of the jigsaw fall into place at the 2016 AACR Conference [Cancer Research UK]

AACR Annual Meeting 2016: A Different Approach to Explaining Environment and Accident in Causing Cancer [CANCER RESEARCH Catalyst]

6. Lutte contre les cancers

Encore une fois [The Economist]

6.1 Observation

Are medical errors really the third most common cause of death in the U.S.? [Science-Based medicine]

Superficial coverage of medical errors could leave erroneous impression with readers [HealthNewsReview]

6.10 Politiques

France’s research minister lays out his priorities [Nature News & Comment]

Moonshot Director Addresses AAADV Workshop [The Cancer Letter]

FDA's Critics Call for Full Integration of Oncology Center Under Biden's Moonshot [The Cancer Letter]

6.11 Patients

'I was too embarrassed to talk about my periods' [BBC News]

6.4 Médico-éco

Cancer costs too high for average Welsh family, charity says [BBC News]

6.5 Médecines alternatives

Australian blogger who claimed natural remedies cured her cancer admits: 'None of it is true' [The Telegraph]

6.6 Publications

Cancer paper that doctored image from Science story earns retraction [Retraction Watch]

6.7 DMP, Big Data & applis

How the ‘internet of DNA’ could solve the mystery of this boy’s disease [The Star]

6.9 Controverses

For science to improve, let’s put the right prizes on offer [STAT]

Stand By Your Data With Some Cash [In the Pipeline]

Google's NHS deal does not bode well for the future of data-sharing [The Guardian]

DeepMind has best privacy infrastructure for handling NHS data, says co-founder [The Guardian]

Time for sharing data to become routine: the seven excuses for not doing so are all invalid [F1000Research]